Dextran Sulfate Sodium Salt (MW 35000-45000): Precision Modeling of Intestinal Inflammation

Principles and Setup: Why DSS Mouse Models Lead in Ulcerative Colitis Research

Dextran sulfate sodium salt (MW 35000-45000), available from APExBIO, is the gold-standard chemical inducer for experimental colitis in rodents. Its polyanionic structure disrupts the colonic epithelial barrier, inducing apoptosis and mimicking key features of human ulcerative colitis, such as mucosal injury, weight loss, and inflammatory cell infiltration (anti-inflammatory-peptide-1.com). This model remains the touchstone for studying inflammatory bowel disease (IBD) pathogenesis, epithelial repair, and for preclinical screening of anti-inflammatory or mucosal-protective agents. DSS is typically administered via drinking water, where its water solubility (≥55.5 mg/mL) ensures rapid preparation and consistent dosing (source: product_spec).

Step-by-Step Workflow: Executing Robust DSS-Induced Colitis Models

Establishing a reproducible mouse model of inflammatory bowel disease with DSS involves careful control of several variables:

• Preparation: Weigh and dissolve the desired amount of DSS powder in sterile, room-temperature drinking water immediately before use to maximize stability. Avoid storing prepared solutions for extended periods (source: product_spec).
• Administration: Replace regular drinking water with DSS-containing water for the induction period, typically 5–7 days, then revert to normal water for recovery. Monitor mice daily for weight, stool consistency, and rectal bleeding.
• Dose Selection: Acute colitis is commonly induced with 2.5%–5% (w/v) DSS, but pilot studies to optimize for mouse strain, age, and experimental question are encouraged (igg-light-chain-variable-region.com).
• Sample Collection: At endpoint, collect colonic tissue for histology, RNA/protein analysis, or flow cytometry. Fecal samples can be retained for microbiome or metabolomic studies.

Protocol Parameters

• assay | 3% (w/v) DSS in water | acute colitis induction in C57BL/6 mice | Balances efficacy and animal welfare; reliably induces weight loss and epithelial injury | article
• assay | 5–7 days administration | acute epithelial damage and inflammation | Mirrors human colitis flare duration and supports mucosal injury/recovery studies | article
• assay | 5 mL/animal/day water intake | dose consistency | Ensures uniform exposure and accurate calculation of DSS consumption per mouse | workflow_recommendation

Key Innovation from the Reference Study

The recent study "Tryptophan metabolic gatekeeping in epithelial repair" (Cell Death and Disease) reveals a paradigm-shifting mechanism in mucosal healing post-DSS injury. It identifies the GPR35-KLF5 circuit as a metabolic sensor and repair driver in intestinal epithelial cells (IECs), orchestrating a precise response to mucosal damage via the tryptophan-kynurenine-kynurenic acid axis. By decoding damage signals and activating a PI3K-AKT-mTOR cascade, this pathway governs IEC proliferation and migration—crucial for restoring the colonic barrier. Practically, this means that DSS-based models are now ideal not only for inducing colitis but also for dissecting the molecular programs underlying mucosal repair, enabling targeted readouts (e.g., GPR35 or KLF5 expression, epithelial proliferation markers) in therapeutic screening or mechanistic studies.

Advanced Applications and Comparative Advantages

DSS (MW 35000-45000) distinguishes itself from lower molecular weight formulations by producing more consistent epithelial disruption and controlled onset of colitis symptoms—critical for reliable ulcerative colitis research (amenamevirsmol.com). This product's high solubility and batch-to-batch reproducibility also support scalability for studies requiring large cohorts or comparative interventions.

Beyond its core use in IBD mouse models, DSS has pivotal roles in:

• Testing candidate anti-inflammatory compounds, probiotics, or dietary interventions by quantifying their impact on DSS-induced injury and repair.
• Evaluating epithelial repair kinetics by integrating molecular readouts (e.g., GPR35, KLF5, or PI3K-AKT-mTOR pathway activity), in line with the reference study’s insights.
• Host-pathogen interaction studies, leveraging DSS-induced barrier disruption to assess susceptibility to enteric infections or the efficacy of antiviral agents (igg-light-chain-variable-region.com).

For example, the article "Dextran Sulfate Sodium Salt (MW 35000-45000): Deep Mechanistic Insights in Intestinal Inflammation Models" complements this workflow by detailing how DSS enables precise modeling of colonic epithelial apoptosis and mucosal repair, directly supporting studies on the molecular circuitry outlined in the reference study. Meanwhile, "Dextran Sulfate Sodium Salt (MW 35000-45000): Optimizing..." extends these findings, offering practical guidance for assay design, troubleshooting, and vendor selection—aligning well with the present guide’s emphasis on reproducibility and product performance.

Troubleshooting and Optimization Tips

Despite its robustness, DSS-induced colitis models require careful optimization to avoid pitfalls:

• Batch-to-Batch Variability: Source DSS (MW 35000-45000) from reputable suppliers such as APExBIO for consistency in molecular weight and sulfation, which are critical for reproducibility (igg-light-chain-variable-region.com).
• Concentration Control: Overly high concentrations (>5%) can cause excessive morbidity or mortality, while too low (<2%) may yield subclinical effects. Always verify optimal dosing for your mouse strain and experimental aims (workflow_recommendation).
• Water Consumption Monitoring: DSS may alter taste and reduce intake, affecting effective dose. Use water bottles with volume markings and monitor daily intake per cage.
• Solution Freshness: DSS solutions are not stable for long-term storage; prepare fresh daily or every 2–3 days and avoid storing at 4°C for extended periods (source: product_spec).
• Animal Welfare: Monitor for rapid weight loss or dehydration. Provide supplemental hydration or early euthanasia if humane endpoints are reached (workflow_recommendation).
• Assay Timing: For mechanistic studies (e.g., GPR35-KLF5 pathway analysis), collect samples at both peak injury (day 7) and during recovery (days 10–14) to capture dynamic repair signatures (workflow_recommendation).

Why this Cross-Domain Matters, Maturity, and Limitations

While DSS is primarily recognized for its role in modeling intestinal inflammation and epithelial repair, its polyanionic nature also inhibits viral adsorption and entry, notably against HIV-1, without significant impact on coagulation pathways (igg-light-chain-variable-region.com). This cross-domain capability enables the use of the same reagent in both immunology/IBD and virology research. However, antiviral applications remain primarily in vitro and preclinical; translation to clinical settings is not yet established (workflow_recommendation).

Future Outlook: Translating Mechanistic Insight into Therapeutic Opportunity

Recent advances, such as the elucidation of the GPR35-KLF5 repair circuit, position DSS-based models at the forefront of precision mucosal repair research. These insights enable researchers to not only model disease, but also to interrogate and target the key molecular signals that govern epithelial regeneration. This is likely to accelerate discovery of novel therapeutics for ulcerative colitis—especially those targeting metabolic sensing or repair programming in IECs (Cell Death and Disease). Ongoing improvements in product quality and protocol standardization, championed by suppliers like APExBIO, will further enhance reproducibility and translational relevance.

In summary, Dextran sulfate sodium salt (MW 35000-45000) remains an indispensable tool for modeling and dissecting the complexities of intestinal inflammation, epithelial repair, and beyond—anchored by robust evidence, workflow flexibility, and cross-domain utility.